Dermatology

2+ hour, 25+ min ago   (795+ words) Social media is driving the trend for "flawless complexions" and complex "glass skin" routines in teenagers, with many prioritising advice from influencers in Get Ready With Me (GRWM) videos over professionals. But do teens really need a multi-step skincare routine?...

9+ hour, 8+ min ago   (145+ words) SAN JOSE, Calif., Sept. 21, 2026 Composition of matter patent secures exclusive protection for Anixa's breast cancer vaccine in Australia through 2040, expanding the Company's growing global IP estate Continues expansion of global intellectual property coverage in markets with increasing breast cancer incidence…...

1+ hour, 19+ min ago   (219+ words) Biotechnology company Moderna will present Phase III trial data for its personalized mRNA cancer vaccine in Madrid, Spain, on October 24. The results of the trial of intismeran in combination with Merck's Keytruda immunotherapy will be presented at the annual meeting…...

6+ hour, 30+ min ago   (563+ words) Sep 21, 2026 | Your Health “Families often tell us that skin disease affects much more than the skin,” says Benjamin Ungar, MD, Director of the Alopecia Center of Excellence at Mount Sinai and a study investigator. “These diseases can be very uncomfortable…...

2+ hour, 51+ min ago   (438+ words) Skincare is supposed to help you take care of your skin. But sometimes, somewhere between TikTok routines, product recommendations, and “you need this” videos, it can start feeling like a full-time job. You have different cleansers, serums, masks, treatments, toners…...

7+ hour, 43+ min ago   (730+ words) The truth about vial counts, delayed results and the 5-5-5 rule. Sculptra is one of those treatments everyone seems to be talking about, but there are still a lot of questions about what it actually does. Is it a filler? How…...

8+ hour, 40+ min ago   (109+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...

5+ hour, 43+ min ago   (519+ words) CancerNetwork...

13+ hour, 15+ min ago   (648+ words) AllSci CUE-221 (UB-221), a dual-mechanism anti-IgE monoclonal antibody being developed by Boston-based Cue Biopharma (Nasdaq: CUE), met both its primary and key secondary endpoints in a Phase II study in chronic spontaneous urticaria (CSU), according to topline results released September…...

11+ hour, 8+ min ago   (471+ words) Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040 Investing News Network Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040 Composition of matter patent secures exclusive protection…...